Is Apollo Hospitals overvalued or undervalued?

Sep 16 2025 08:02 AM IST
share
Share Via
As of September 15, 2025, Apollo Hospitals is considered undervalued with an attractive valuation grade, featuring a PE Ratio of 71.39, a lower PEG Ratio of 1.38 compared to peers, and a 11.45% return over the past year, outperforming the Sensex's decline of 1.33%.
As of 15 September 2025, Apollo Hospitals has moved from a fair to an attractive valuation grade, indicating a positive shift in its market perception. The company is currently considered undervalued. Key ratios include a PE Ratio of 71.39, an EV to EBITDA of 36.71, and a ROE of 17.61%.
In comparison to its peers, Apollo Hospitals stands out with a lower PEG Ratio of 1.38, while Max Healthcare and Fortis Health are significantly more expensive with PE Ratios of 94.84 and 79.9, respectively. Despite a recent dip in stock price, Apollo Hospitals has outperformed the Sensex over the past year with a return of 11.45%, compared to the Sensex's decline of 1.33%.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News